Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Aug 14, 2012, before the open
10-Q filed Aug 14, 2012, 45 days after period end · 0001445305-12-002636
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2011 | Q2 2010 | Q2 2009 |
|---|---|---|---|
| Revenue | $3.37M | $2.21M | $19.41M |
| Net Income | -$20.51M | -$10.61M | -$5.37M |
| EPS Diluted | -$1.53 | -$0.13 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
